Linda Scaramuzza
Milan, 20122, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Corrigendum to "Transplanted human striatal progenitors exhibit functional integration and modulate host circuitry in a Huntington's disease animal model" [Pharmacol. Res. 219 (2025) 107905].
Journal: Pharmacological research
Published: April 05, 2026
Corrigendum to Transplanted human striatal progenitors exhibit functional integration and modulate host circuitry in a Huntington's disease animal model [Pharmacol. Res. volume 219:107905 (2025)].
Journal: Pharmacological research
Published: August 28, 2025
Transplanted human striatal progenitors exhibit functional integration and modulate host circuitry in a Huntington's disease animal model.
Journal: Pharmacological research
Published: July 17, 2025
hESC-derived striatal progenitors grafted into a Huntington's disease rat model support long-term functional motor recovery by differentiating, self-organizing and connecting into the lesioned striatum.
Journal: Stem cell research & therapy
Published: January 16, 2023
The enhancement of activity rescues the establishment of Mecp2 null neuronal phenotypes.
Journal: EMBO molecular medicine
Published: April 04, 2020
The antidepressant tianeptine reverts synaptic AMPA receptor defects caused by deficiency of CDKL5.
Journal: Human molecular genetics
Published: February 21, 2018
Lack of Methyl-CpG Binding Protein 2 (MeCP2) Affects Cell Fate Refinement During Embryonic Cortical Development.
Journal: Cerebral cortex (New York, N.Y. : 1991)
Published: June 30, 2017
MeCP2 Related Studies Benefit from the Use of CD1 as Genetic Background.
Journal: PloS one
Published: June 11, 2015
Defects During Mecp2 Null Embryonic Cortex Development Precede the Onset of Overt Neurological Symptoms.
Journal: Cerebral cortex (New York, N.Y. : 1991)
Published: May 17, 2015
Showing 1-10 of 10
Last Updated: 09/26/2026